Selective anticoagulation with active site-blocked factor IXa suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass
Open Access
- 30 November 1998
- journal article
- Published by Elsevier BV in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 116 (5), 860-869
- https://doi.org/10.1016/s0022-5223(98)00437-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Heparinless cardiopulmonary bypass with active-site blocked factor IXa: A preliminary study on the dogThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: A clinical studyThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypassThe Annals of Thoracic Surgery, 1995
- Hemostatic complications of cardiopulmonary bypassAmerican Journal of Hematology, 1995
- Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypassThe Lancet, 1994
- Tissue factor is expressed on monocytes during simulated extracorporeal circulation.Circulation Research, 1993
- Blood-Surface Interactions During Cardiopulmonary BypassJournal of Cardiac Surgery, 1993
- Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model.JCI Insight, 1991
- Tissue factor induction in human monocytes. Two distinct mechanisms displayed by different alloantigen-responsive T cell clones.JCI Insight, 1985
- Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa.JCI Insight, 1981